SCHEMBL30504281

SCHEMBL30504281

[2H]c1cc(C(F)(F)F)cc(NC(N)=O)c1F

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 7/20 0.55
KDR P35968 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TSHR P16473 1/20 0.46
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
TMPRSS4 Q9NRS4 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
PTGS1 P23219 2/20 0.43
ALDH1A1 P00352 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL60290 0.85 KIF11 (0.63) KIF11KDRMEN1KMT2ATSHR
SCHEMBL29572624 0.85 KIF11 (0.63) KIF11KDRMEN1KMT2ATSHR
SCHEMBL29416601 0.79 KIF11 (0.77) KIF11MEN1KMT2ATSHRTRPV1
SCHEMBL14959294 0.79 KIF11 (0.77) KIF11MEN1KMT2ATSHRTRPV1
SCHEMBL7759291 0.76 MEN1 (0.56) KIF11KDRMEN1KMT2ACA12
SCHEMBL30499687 0.76 MEN1 (0.56) KIF11KDRMEN1KMT2ACA12
SCHEMBL20557336 0.76 MEN1 (0.75) KIF11MEN1KMT2ACA12CA1
SCHEMBL28141674 0.74 TAS2R14 (0.57) KIF11MEN1KMT2ATSHRALDH1A1
SCHEMBL1091582 0.74 ALDH1A1 (0.66) MEN1KMT2ATSHRTRPV1ALDH1A1
SCHEMBL30377979 0.72 DGAT1 (0.43) KIF11KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117120442-A Tricyclic compounds useful for treating cancer, autoimmune disorders, and inflammatory disorders 薛定谔公司 2023-11-24 CN disclosed
CN-117120447-A Cyclic compounds and methods of use thereof 薛定谔公司 2023-11-24 CN disclosed
CN-116490507-A Heterocyclic condensation CDC7 kinase inhibitors for the treatment of cancer 薛定谔公司 2023-07-25 CN disclosed